Skip to content
10-Q

Quarterly Report

TOURMALINE BIO, INC.

0001827506-25-000060

← back to feed
Filed
May 2, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 25, 2025 25.69M sh
Shares Diluted Q1 2025 · Mar 31, 2025 25.69M sh
Shares Diluted Q1 2025 · Mar 31, 2024 24.08M sh
Stock Repurchased Q1 2025 · Mar 31, 2025 $7K
Stock Repurchased Q1 2025 · Mar 31, 2024 $0
Capex Q1 2025 · Mar 31, 2025 $9K
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$21.68M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$14.92M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $35.33M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $30.51M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $98.29M
Stockholders Equity Q1 2025 · Mar 31, 2025 $279.86M
Stockholders Equity Q1 2025 · Dec 31, 2024 $300.05M
Stockholders Equity Q1 2025 · Mar 31, 2024 $354.14M
Stockholders Equity Q1 2025 · Dec 31, 2023 $205.04M
Current Liabilities Q1 2025 · Mar 31, 2025 $7.62M
Current Liabilities Q1 2025 · Dec 31, 2024 $8.91M
Total Liabilities Q1 2025 · Mar 31, 2025 $7.64M
Total Liabilities Q1 2025 · Dec 31, 2024 $8.95M
Current Assets Q1 2025 · Mar 31, 2025 $258.14M
Current Assets Q1 2025 · Dec 31, 2024 $268.84M
Total Assets Q1 2025 · Mar 31, 2025 $287.5M
Total Assets Q1 2025 · Dec 31, 2024 $309M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.89
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.55
Eps Basic Q1 2025 · Mar 31, 2025 −$0.89
Eps Basic Q1 2025 · Mar 31, 2024 −$0.55
Sga Expense Q1 2025 · Mar 31, 2025 $5.97M
Sga Expense Q1 2025 · Mar 31, 2024 $6.14M
Rd Expense Q1 2025 · Mar 31, 2025 $20.26M
Rd Expense Q1 2025 · Mar 31, 2024 $11.38M
Net Income Q1 2025 · Mar 31, 2025 −$22.97M
Net Income Q1 2025 · Mar 31, 2024 −$13.31M
Operating Income Q1 2025 · Mar 31, 2025 −$26.23M
Operating Income Q1 2025 · Mar 31, 2024 −$17.52M